Breaking News Instant updates and real-time market news.

NTRA

Natera

$22.90

-0.88 (-3.70%)

08:44
06/03/19
06/03
08:44
06/03/19
08:44

Natera's Signatera test detects immunotherapy treatment response in new study

A new study demonstrates the ability of Natera's Signatera test to assess patient response to immunotherapy in the metastatic setting across multiple cancer types by detecting molecular traces of circulating tumor DNA in the blood. The study was presented at the American Society of Clinical Oncology Annual Meeting in Chicago on June 1. The study, conducted by Princess Margaret Cancer Centre in Toronto, enrolled 70 patients with advanced cancer, including head and neck, triple-negative breast, melanoma, and ovarian cancers. Patients were treated with the single-agent immune checkpoint inhibitor pembrolizumab as part of the phase II INSPIRE trial. The study used Signatera to assess ctDNA at baseline and again at the start of the third treatment cycle. Results showed a strong correlation between changes in ctDNA and overall survival, progression-free survival, and overall clinical response rate, illustrating that ctDNA may be a valuable predictive biomarker for patients with mixed solid tumors treated with checkpoint inhibitors. Signatera, a personalized, tumor-informed blood test, detected ctDNA in 68 out of 70 patients at baseline (97% sensitivity).

NTRA Natera
$22.90

-0.88 (-3.70%)

03/11/19
PIPR
03/11/19
NO CHANGE
Target $23
PIPR
Overweight
Natera partnership removes financing risk through 2020, says Piper Jaffray
Piper Jaffray analyst William Quirk says he likes the "non-dilutive funding" from Natera's 10-year partnership agreement with BGI Genomics and believes the deal removes the company's financing risk through at least 2020. Further, BGI is a major sequencing provider in China and this deal immediately expands Natera's access to this large market, Quirk tells investors in a research note. This "looks like a smart deal for both parties," says Quirk, who reiterates an Overweight rating on Natera with a $23 price target.
03/28/19
RAJA
03/28/19
NO CHANGE
RAJA
Strong Buy
CareDx lawsuit against Natera 'not unexpected,' says Raymond James
Raymond James analyst John Hsu notes that CareDx (CDNA) announced the filing of a patent infringement lawsuit against Natera (NTRA), which was "not unexpected." The analyst sees the lawsuit as consistent with management seeking to protect the company's intellectual property, and notes that the court process could take up to three years. While this lawsuit is a "logical course of action," Hsu believes CareDx remains focused on building its moat in kidney transplant, with sales force investments and a focus on integration with hospital electronic medical records. Overall, the analyst still views 2019's main focus on other activities to strengthen a "significant head start on the back of a best-in-class product launch in 2018." He reiterates a Strong Buy rating on CareDx shares.
03/29/19
ADAM
03/29/19
NO CHANGE
Target $27
ADAM
Buy
Natera draft local coverage decision a 'positive surprise,' says Canaccord
Canaccord analyst Mark Massaro said he was positively surprised that Natera was issued a draft local coverage decision by Palmetto MolDx for its blood-based kidney transplant rejection test, as he sees the news increasing the probability that the test launches with Medicare reimbursement. Even after yesterday's move higher on this news, Natera shares trade at a "material disconnect" to what the business is actually worth, Massaro contends. He raised his price target on the stock to $27 from $26 and keeps a Buy rating on Natera, adding that the stock "is at the top of our list of top picks for 2019."
04/04/19
BARD
04/04/19
NO CHANGE
Target $24
BARD
Outperform
Natera remains 'top idea' following management meetings, says Baird
Baird analyst Catherine Ramsey Schulte maintained an Outperform rating and $24 price target on Natera, saying she continues to recommend Natera as a top idea following recent investor meetings with CEO Steve Chapman and CFO Mike Brophy. The analyst thinks Natera's core business is healthy and believes transplant and oncology opportunities are only partially valued in the stock today and could drive meaningful upside over the next few years.

TODAY'S FREE FLY STORIES

PZZA

Papa John's

$54.85

1.73 (3.26%)

14:25
10/16/19
10/16
14:25
10/16/19
14:25
Options
Papa John's call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Oct

  • 13

    Nov

PINC

Premier

$31.89

0.47 (1.50%)

, GE

General Electric

$8.90

0.015 (0.17%)

14:23
10/16/19
10/16
14:23
10/16/19
14:23
Hot Stocks
Premier, GE collaborating on U.S. model for same-day breast cancer diagnosis »

GE Healthcare (GE) and…

PINC

Premier

$31.89

0.47 (1.50%)

GE

General Electric

$8.90

0.015 (0.17%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Oct

  • 05

    Nov

  • 19

    Nov

  • 20

    Nov

PLCE

Children's Place

$76.39

0.36 (0.47%)

, SCVL

Shoe Carnival

$33.81

0.52 (1.56%)

14:21
10/16/19
10/16
14:21
10/16/19
14:21
Periodicals
Mox sees potential 40%-60% upside in Children's Place, Shoe Carnival »

Mox Reports said in a new…

PLCE

Children's Place

$76.39

0.36 (0.47%)

SCVL

Shoe Carnival

$33.81

0.52 (1.56%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

14:20
10/16/19
10/16
14:20
10/16/19
14:20
General news
Fed's Beige Book reported the expansion was at a "slight to modest pace," »

Fed's Beige Book…

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

14:17
10/16/19
10/16
14:17
10/16/19
14:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

14:16
10/16/19
10/16
14:16
10/16/19
14:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SNY

Sanofi

$45.72

0.17 (0.37%)

, BAX

Baxter

$87.08

-0.68 (-0.77%)

14:16
10/16/19
10/16
14:16
10/16/19
14:16
Periodicals
Sanofi in advanced talks to sell Seprafilm to Baxter, Bloomberg reports »

Sanofi (SNY) is in…

SNY

Sanofi

$45.72

0.17 (0.37%)

BAX

Baxter

$87.08

-0.68 (-0.77%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 31

    Oct

  • 06

    Nov

ATVI

Activision Blizzard

$55.61

0.04 (0.07%)

14:08
10/16/19
10/16
14:08
10/16/19
14:08
Periodicals
Blizzard bans 'Hearthstone' team for 6 months after Hong Kong sign, Kotaku says »

"Hearthstone"…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

  • 07

    Nov

CLDR

Cloudera

$8.91

0.105 (1.19%)

14:05
10/16/19
10/16
14:05
10/16/19
14:05
Options
Cloudera call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$298.25

-0.65 (-0.22%)

14:03
10/16/19
10/16
14:03
10/16/19
14:03
General news
Most Fed districts reported 'modest' pace of price increases »

The Federal…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$298.25

-0.65 (-0.22%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$298.22

-0.68 (-0.23%)

14:02
10/16/19
10/16
14:02
10/16/19
14:02
General news
Employment rose slightly 'on balance,' Fed says in Beige Book »

The Federal…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$298.22

-0.68 (-0.23%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$298.18

-0.72 (-0.24%)

14:01
10/16/19
10/16
14:01
10/16/19
14:01
General news
U.S. economy expanded at 'slight to modest pace,' Fed says in Beige Book »

The Federal…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$298.18

-0.72 (-0.24%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

13:55
10/16/19
10/16
13:55
10/16/19
13:55
Conference/Events
Joint Economic Committee to hold a hearing »

The Committee holds a…

TMUS

T-Mobile

$79.88

0.125 (0.16%)

, S

Sprint

$6.45

-0.03 (-0.46%)

13:52
10/16/19
10/16
13:52
10/16/19
13:52
Periodicals
T-Mobile, Sprint deal 'appears to have cleared' FCC vote, Bloomberg says »

Bloomberg headlines…

TMUS

T-Mobile

$79.88

0.125 (0.16%)

S

Sprint

$6.45

-0.03 (-0.46%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

13:45
10/16/19
10/16
13:45
10/16/19
13:45
General news
Breaking General news story  »

Beige Book to be released…

PNC

PNC Financial

$140.90

1.34 (0.96%)

13:45
10/16/19
10/16
13:45
10/16/19
13:45
Conference/Events
The Brookings Institution to hold a discussion on recession preparation »

Brookings hosts a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

  • 16

    Oct

  • 16

    Oct

IBM

IBM

$141.89

-1.09 (-0.76%)

, FB

Facebook

$188.69

-0.12 (-0.06%)

13:43
10/16/19
10/16
13:43
10/16/19
13:43
Earnings
Fly Intel: What to watch in IBM's earnings report »

IBM (IBM) is scheduled to…

IBM

IBM

$141.89

-1.09 (-0.76%)

FB

Facebook

$188.69

-0.12 (-0.06%)

V

Visa

$177.59

-1.21 (-0.68%)

PYPL

PayPal

$102.54

-1 (-0.97%)

EBAY

eBay

$38.92

0.04 (0.10%)

MA

MasterCard

$277.70

-0.94 (-0.34%)

BKNG

Booking Holdings

$2,025.61

7.98 (0.40%)

MSFT

Microsoft

$139.94

-1.62 (-1.14%)

GOOG

Alphabet

$1,243.61

0.08 (0.01%)

GOOGL

Alphabet Class A

$1,243.00

0.49 (0.04%)

INTC

Intel

$52.14

-0.505 (-0.96%)

BABA

Alibaba

$176.05

0.74 (0.42%)

SFTBF

SoftBank

$0.00

(0.00%)

BIDU

Baidu

$108.33

1.115 (1.04%)

SCMWY

Swisscom

$0.00

(0.00%)

TCEHY

Tencent

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

  • 16

    Oct

  • 16

    Oct

  • 18

    Oct

  • 23

    Oct

  • 23

    Oct

  • 23

    Oct

  • 23

    Oct

  • 24

    Oct

  • 24

    Oct

  • 26

    Oct

  • 27

    Oct

  • 28

    Oct

  • 28

    Oct

  • 29

    Oct

  • 29

    Oct

  • 29

    Oct

  • 30

    Oct

  • 31

    Oct

  • 06

    Nov

  • 19

    Nov

  • 20

    Nov

  • 21

    Nov

M

Macy's

$15.77

0.07 (0.45%)

13:35
10/16/19
10/16
13:35
10/16/19
13:35
Options
Macy's put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

FB

Facebook

$188.59

-0.22 (-0.12%)

13:32
10/16/19
10/16
13:32
10/16/19
13:32
Hot Stocks
Facebook unveils ReAgent to help build models that make and rely on decisions »

Jason Gauci, Honglei Liu,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 27

    Oct

  • 30

    Oct

PINS

Pinterest

$25.70

0.1 (0.39%)

13:27
10/16/19
10/16
13:27
10/16/19
13:27
Upgrade
Pivotal upgrades Pinterest to Buy after 30% pullback from highs »

Pivotal Research analyst…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

  • 31

    Oct

  • 19

    Nov

  • 16

    Oct

ALGN

Align Technology

$211.62

2.32 (1.11%)

13:25
10/16/19
10/16
13:25
10/16/19
13:25
Options
Align Technology call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

13:25
10/16/19
10/16
13:25
10/16/19
13:25
Conference/Events
Stephens food/agribusiness analyst to hold analyst/industry conference call »

Analysts, along with…

13:25
10/16/19
10/16
13:25
10/16/19
13:25
Conference/Events
Wedbush technology analyst to hold an analyst/industry webcast »

Technology Analyst…

PINS

Pinterest

$25.69

0.09 (0.35%)

13:21
10/16/19
10/16
13:21
10/16/19
13:21
Upgrade
Pinterest rating change  »

Pinterest upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

  • 31

    Oct

  • 19

    Nov

  • 16

    Oct

PM

Philip Morris

$79.09

0.77 (0.98%)

, HON

Honeywell

$163.93

0.27 (0.16%)

13:19
10/16/19
10/16
13:19
10/16/19
13:19
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

PM

Philip Morris

$79.09

0.77 (0.98%)

HON

Honeywell

$163.93

0.27 (0.16%)

UNP

Union Pacific

$163.27

0.07 (0.04%)

MS

Morgan Stanley

$42.80

0.26 (0.61%)

BBT

BB&T

$52.81

0.06 (0.11%)

STI

SunTrust

$68.01

-0.04 (-0.06%)

PPG

PPG

$119.43

1.21 (1.02%)

MTB

M&T Bank

$158.77

-0.1 (-0.06%)

KEY

KeyCorp

$17.63

-0.15 (-0.84%)

GPC

Genuine Parts

$97.95

0.01 (0.01%)

DOV

Dover

$95.93

-0.02 (-0.02%)

TXT

Textron

$50.56

-0.11 (-0.22%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

  • 17

    Oct

  • 17

    Oct

  • 17

    Oct

  • 17

    Oct

  • 17

    Oct

  • 17

    Oct

  • 17

    Oct

  • 17

    Oct

  • 17

    Oct

  • 17

    Oct

  • 17

    Oct

  • 17

    Oct

  • 04

    Nov

  • 08

    Nov

  • 10

    Nov

  • 11

    Nov

  • 12

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.